Ensysce Biosciences, Inc. (ENSC)

NASDAQ: ENSC · Real-Time Price · USD

1.640

+0.010 (0.61%)

At close: Dec 5, 2025, 4:00 PM EST

1.660

+0.020 (1.22%)

After-hours: Dec 5, 2025, 4:32 PM EST

Ensysce Biosciences Employees

As of December 31, 2024, Ensysce Biosciences had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees increased by 1 or 14.29% compared to the previous year.

Employees

Change (1Y)

Growth (1Y)

14.29%

Revenue / Employee

$560,997

Profits / Employee

-$1,371,559

Market Cap

5.81M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	8	1	14.29%
Dec 31, 2023	7	0	-
Dec 31, 2022	7	1	16.67%
Dec 31, 2021	6	3	100.00%
Dec 31, 2020	3	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

ENSC News

4 days ago - Ensysce Biosciences Announces Broader Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology - Accesswire
16 days ago - Ensysce Biosciences Receives Positive FDA Feedback on PF614 Manufacturing Approach - Accesswire
19 days ago - Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs - Accesswire
21 days ago - Ensysce Biosciences Reports Third Quarter 2025 Financial Results - Accesswire
2 months ago - Ensysce Biosciences Releases Symposium Highlights from PAINWeek 2025 - Accesswire
3 months ago - Ensysce Biosciences Showcases Urgent Need for Safer Opioids at PAINWeek 2025 Symposium - Accesswire
3 months ago - Ensysce Biosciences' Geoff Birkett to Chair the Fierce New Product Planning Summit 2025 - Accesswire
4 months ago - Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC) - GlobeNewsWire

More News